COVID ops.

Unfortunately the transmission of COVID-19 has far outpaced our ability to produce well-designed phase 3 therapeutic trials with rigorous follow-up and analysis. Here’s a comprehensive review of what little we do know thus far about various agents purported to lessen disease severity. | Sanders, JAMA 2020